Icmr Clinical Trials
- All
- News
- Videos
-
Tissue Sample Moved 37 Km In 20 Min, Mid-Surgery, For Cancer Testing
- Wednesday April 10, 2024
- India News | Press Trust of India
The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.
- www.ndtv.com
-
India Completes Clinical Trials Of World's 1st Injectable Male Contraceptive
- Thursday October 19, 2023
- India News | Press Trust of India
The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.
- www.ndtv.com
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
- Tuesday January 5, 2021
- India News | Press Trust of India
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
- www.ndtv.com
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
- Thursday November 12, 2020
- India News | Press Trust of India
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
- www.ndtv.com
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
- Wednesday November 11, 2020
- India News | Written by Sukirti Dwivedi
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
- www.ndtv.com
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
- Friday October 23, 2020
- India News | Reported by Sharad Sharma, Edited by Divyanshu Dutta Roy
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
- www.ndtv.com
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
- Wednesday October 7, 2020
- India News | Press Trust of India
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
- www.ndtv.com
-
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
- Tuesday September 15, 2020
- India News | Press Trust of India
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
- www.ndtv.com
-
If Centre Decides: Top Medical Body On COVID-19 Vaccine's Emergency Authorisation
- Thursday August 20, 2020
- India News | Press Trust of India
A top ICMR official told a parliamentary panel on Wednesday that phase-two clinical trial of two indigenously developed COVID-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the centre decides so.
- www.ndtv.com
-
3 Covid Vaccines In Different Phases Of Testing, Says Top Medical Body
- Wednesday August 5, 2020
- India News | Pres Trust of India
The Phase 1 human clinical trials of two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been completed and the trials have moved to Phase 2, ICMR Director General Balram Bhargava said on Tuesday.
- www.ndtv.com
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
- Thursday July 23, 2020
- India News | Press Trust of India
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
- www.ndtv.com
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
- Thursday July 23, 2020
- India News | Press Trust of India
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
- www.ndtv.com
-
Human Clinical Trials For COVID Vaccine Initiated In India: Top Medical Body ICMR
- Tuesday July 14, 2020
- India News | Press Trust of India
Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates, the ICMR said on Tuesday.
- www.ndtv.com
-
Over 1,100 People For Clinical Trials Of India's First Covid Vaccine
- Monday July 6, 2020
- India News | Reported by Arvind Gunasekar, Edited by Chandrashekar Srinivasan
More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday. Phase I clinical trials are scheduled to start next week, with July 13 set as the date for participant enrolment. Results from Phase I wi...
- www.ndtv.com
-
Don't Restrict Plasma Therapy To Critical Covid Cases: Mumbai Doctors
- Friday June 26, 2020
- Mumbai News | Written by Saurabh Gupta
Adopt plasma therapy sooner for potentially complicated Covid patients and counsel survivors to donate plasma, doctors on the frontline of battle against coronavirus in Mumbai said, suggesting there needs to be a shift in use of plasma therapy to save more lives in Mumbai.
- www.ndtv.com
-
Tissue Sample Moved 37 Km In 20 Min, Mid-Surgery, For Cancer Testing
- Wednesday April 10, 2024
- India News | Press Trust of India
The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.
- www.ndtv.com
-
India Completes Clinical Trials Of World's 1st Injectable Male Contraceptive
- Thursday October 19, 2023
- India News | Press Trust of India
The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.
- www.ndtv.com
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
- Tuesday January 5, 2021
- India News | Press Trust of India
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
- www.ndtv.com
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
- Thursday November 12, 2020
- India News | Press Trust of India
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
- www.ndtv.com
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
- Wednesday November 11, 2020
- India News | Written by Sukirti Dwivedi
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
- www.ndtv.com
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
- Friday October 23, 2020
- India News | Reported by Sharad Sharma, Edited by Divyanshu Dutta Roy
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
- www.ndtv.com
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
- Wednesday October 7, 2020
- India News | Press Trust of India
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
- www.ndtv.com
-
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
- Tuesday September 15, 2020
- India News | Press Trust of India
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
- www.ndtv.com
-
If Centre Decides: Top Medical Body On COVID-19 Vaccine's Emergency Authorisation
- Thursday August 20, 2020
- India News | Press Trust of India
A top ICMR official told a parliamentary panel on Wednesday that phase-two clinical trial of two indigenously developed COVID-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the centre decides so.
- www.ndtv.com
-
3 Covid Vaccines In Different Phases Of Testing, Says Top Medical Body
- Wednesday August 5, 2020
- India News | Pres Trust of India
The Phase 1 human clinical trials of two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been completed and the trials have moved to Phase 2, ICMR Director General Balram Bhargava said on Tuesday.
- www.ndtv.com
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
- Thursday July 23, 2020
- India News | Press Trust of India
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
- www.ndtv.com
-
Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech
- Thursday July 23, 2020
- India News | Press Trust of India
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.
- www.ndtv.com
-
Human Clinical Trials For COVID Vaccine Initiated In India: Top Medical Body ICMR
- Tuesday July 14, 2020
- India News | Press Trust of India
Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates, the ICMR said on Tuesday.
- www.ndtv.com
-
Over 1,100 People For Clinical Trials Of India's First Covid Vaccine
- Monday July 6, 2020
- India News | Reported by Arvind Gunasekar, Edited by Chandrashekar Srinivasan
More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday. Phase I clinical trials are scheduled to start next week, with July 13 set as the date for participant enrolment. Results from Phase I wi...
- www.ndtv.com
-
Don't Restrict Plasma Therapy To Critical Covid Cases: Mumbai Doctors
- Friday June 26, 2020
- Mumbai News | Written by Saurabh Gupta
Adopt plasma therapy sooner for potentially complicated Covid patients and counsel survivors to donate plasma, doctors on the frontline of battle against coronavirus in Mumbai said, suggesting there needs to be a shift in use of plasma therapy to save more lives in Mumbai.
- www.ndtv.com